Funding

2019-2022 ERA-CVD Nr 56 – INNOVATION: Investigating long non-coding RNA regulated pathways driving cardiac regeneration; PI of the Portuguese Participant Institution: 93.750€ (Total: 1.093.750 €)

2018-2021 Age-related epigenetic barriers during cellular reprogramming. Funding Agency: FCT (Total Funding: €239.555,21- Co-Principal Investigator)

2018-2021 The role of long non-coding RNAs on the molecular circuitry and metabolic adaptation of breast cancer. Funding Agency: FCT (Total Funding: 238.211,41 € - Principal Investigator)

2016-2019 SAICTPAC/0021/2015 - Accelerating progress toward the new era of precision medicine. Coordinator: Maria Carmo-Fonseca (Total Funding: €2.499.827,90 – Participant)

2015-2019 FCT R&D Projects 2014 - PTDC/BIM-MED/0032/2014 - (Total Funding: €188.175,00 - Principal Investigator)

2015-2020 Exploratory Research Project under iFCT Program (€ 49.961,00 - Principal Investigator)

2015 I Contest AstraZeneca Foundation. 1st poster prize to Catarina Vale (€ 3.000). Catarina Alves-Vale, Sara Barros, Bruno Bernardes de Jesus*, Maria Carmo-Fonseca*